F-18 FDG PET/CT as a valuable imaging tool for assessing treatment efficacy in inflammatory and infectious diseases.
Imperiale
Alessio
A
Service de Biophysique et de Médecine Nucléaire, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. alessio.imperiale@chru-strasbourg.fr
Federici
Laure
L
Lefebvre
Nicolas
N
Braun
Jean-Jacques
JJ
Pfumio
Francis
F
Kessler
Romain
R
Hansmann
Yves
Y
Andres
Emmanuel
E
Constantinesco
André
A
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007239:Infections / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000628:therapy*; D007249:Inflammation / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D049268:Positron-Emission Tomography; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D019788:Fluorodeoxyglucose F18